Serum Metabolic Profiling Reveals Altered Metabolic Pathways in Patients with Post-traumatic Cognitive Impairments

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yi, Lunzhao ^a   Shi, Shuting ^b   Wang, Yang ^c   Huang, Wei ^c   Xia, Zi An ^c   Xing, Zhihua ^c   Peng, Weijun ^d   Wang, Zhe ^d  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BIOLOGY; CASE CONTROL STUDY; COGNITIVE DYSFUNCTION; COMPLICATION; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLOME; METABOLOMICS; MIDDLE AGED; PROCEDURES; TRAUMATIC BRAIN INJURY; YOUNG ADULT;

ADULT; AGED; BRAIN INJURIES, TRAUMATIC; CASE-CONTROL STUDIES; COGNITIVE DYSFUNCTION; COMPUTATIONAL BIOLOGY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MIDDLE AGED; YOUNG ADULT;

EID: 84958818630     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21320     Document Type: Article

References (57)

1. Wortzel, H. S., Arciniegas, D. B. Treatment of post-traumatic cognitive impairments. Curr Treat Options Neurol 14, 493-508, doi: 10.1007/s11940-012-0193-6 (2012).
2. Walker, K. R., Tesco, G. Molecular mechanisms of cognitive dysfunction following traumatic brain injury. Front Aging Neurosci 5, 29, doi: 10.3389/fnagi.2013.00029 (2013).
3. Rabinowitz, A. R., Levin, H. S. Cognitive sequelae of traumatic brain injury. Psychiatr Clin North Am 37, 1-11, doi: 10.1016/j. psc.2013.11.004 (2014).
4. Levin, H. S., Robertson, C. S. Mild traumatic brain injury in translation. J Neurotrauma 30, 610-617, doi: 10.1089/neu.2012.2394 (2013).
5. Dikmen, S. S. et al. Cognitive outcome following traumatic brain injury. J Head Trauma Rehabil 24, 430-438, doi: 10.1097/HTR.0b013e3181c133e9 (2009).
6. Kinnunen, K. M. et al. White matter damage and cognitive impairment after traumatic brain injury. Brain 134, 449-463, doi: 10.1093/brain/awq347 (2011).
7. Peng, W. et al. Impact of statins on cognitive deficits in adult male rodents after traumatic brain injury: a systematic review. Biomed Res Int 2014, 261409, doi: 10.1155/2014/261409 (2014).
8. Bachstetter, A. D. et al. Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic. J Neuroinflammation 12, 69, doi: 10.1186/s12974-015-0289-5 (2015).
9. Weng, R. et al. Metabolomics Approach Reveals Integrated Metabolic Network Associated with Serotonin Deficiency. Sci Rep 5, 11864, doi: 10.1038/srep11864 (2015).
10. Ellis, J. K. et al. Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population. BMC Med 10, 61, doi: 10.1186/1741-7015-10-61 (2012).
11. Maitre, L. et al. Urinary metabolic profiles in early pregnancy are associated with preterm birth and fetal growth restriction in the Rhea mother-child cohort study. BMC Med 12, 110, doi: 10.1186/1741-7015-12-110 (2014).
12. Xu, X. H., Huang, Y., Wang, G., Chen, S. D. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease. Neurosci Bull 28, 641-648, doi: 10.1007/s12264-012-1272-0 (2012).
13. Wang, J. H., Byun, J., Pennathur, S. Analytical approaches to metabolomics and applications to systems biology. Semin Nephrol 30, 500-511, doi: 10.1016/j.semnephrol.2010.07.007 (2010).
14. Glenn, T. C. et al. Metabolomic analysis of cerebral spinal fluid from patients with severe brain injury. Acta Neurochir Suppl 118, 115-119, doi: 10.1007/978-3-7091-1434-6-20 (2013).
15. Viant, M. R., Lyeth, B. G., Miller, M. G., Berman, R. F. An NMR metabolomic investigation of early metabolic disturbances following traumatic brain injury in a mammalian model. NMR Biomed 18, 507-516, doi: 10.1002/nbm.980 (2005).
16. Robertson, C. L. et al. Cerebral glucose metabolism in an immature rat model of pediatric traumatic brain injury. J Neurotrauma 30, 2066-2072, doi: 10.1089/neu.2013.3007 (2013).
17. Lin, Z. et al. Exploring metabolic syndrome serum profiling based on gas chromatography mass spectrometry and random forest models. Anal Chim Acta 827, 22-27, doi: 10.1016/j.aca.2014.04.008 (2014).
18. Yi, L. et al. Metabolomic identification of novel biomarkers of nasopharyngeal carcinoma. RSC Adv. 4, 59094-59101, doi: 10.1039/c4ra09860a (2014).
19. Gonzalez-Dominguez, R., Garcia-Barrera, T., Gomez-Ariza, J. L. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease. J Pharm Biomed Anal 107, 75-81, doi: 10.1016/j.jpba.2014.10.010 (2015).
20. Liu, S. et al. Application of GC-MS coupled with chemometrics for scanning serum metabolic biomarkers from renal fibrosis rat. Biochem Biophys Res Commun 461, 186-192, doi: 10.1016/j.bbrc.2015.04.031 (2015).
21. Wang, Z. et al. Serum Metabolomics in Rats after Acute Paraquat Poisoning. Biol Pharm Bull 38, 1049-1053, doi: 10.1248/bpb.b15-00147 (2015).
22. Chen, Y. et al. Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry. J Cancer Res Clin Oncol 141, 705-718, doi: 10.1007/s00432-014-1846-5 (2015).
23. Louin, G. et al. Plasma concentrations of arginine and related amino acids following traumatic brain injury: Proline as a promising biomarker of brain damage severity. Nitric Oxide 17, 91-97, doi: 10.1016/j.niox.2007.05.006 (2007).
24. Hashimoto, K. et al. Possible role of d-serine in the pathophysiology of Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28, 385-388, doi: 10.1016/j.pnpbp.2003.11.009 (2004).
25. Li, N. et al. Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: a metabolomics study. J Chromatogr B Analyt Technol Biomed Life Sci 985, 54-61, doi: 10.1016/j.jchromb.2015.01.016 (2015).
26. Madeira, C. et al. d-serine levels in Alzheimer's disease: implications for novel biomarker development. Transl Psychiatry 5, e561, doi: 10.1038/tp.2015.52 (2015).
27. Trushina, E., Dutta, T., Persson, X. M., Mielke, M. M., Petersen, R. C. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. PLoS One 8, e63644, doi: 10.1371/journal. pone.0063644 (2013).
28. de Koning, T. J. et al. L-serine in disease and development. Biochem J 371, 653-661, doi: 10.1042/BJ20021785 (2003).
29. Wissmann, P., Geisler, S., Leblhuber, F., Fuchs, D. Immune activation in patients with Alzheimer's disease is associated with high serum phenylalanine concentrations. J Neurol Sci 329, 29-33, doi: 10.1016/j.jns.2013.03.007 (2013).
30. Drago, F. et al. Pyroglutamic acid improves learning and memory capacities in old rats. Funct Neurol 3, 137-143 (1988).
31. Pepeu, G., Spignoli, G. Nootropic drugs and brain cholinergic mechanisms. Prog Neuropsychopharmacol Biol Psychiatry 13 Suppl, S77-88 (1989).
32. Adibhatla, R. M., Hatcher, J. F. Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49, 241-268, doi: 10.1007/978-1-4020-8831-5-9 (2008).
33. Bales, K. R. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology 59, 295-302, doi: 10.1016/j.neuropharm.2010.01.005 (2010).
34. Sanchez-Mejia, R. O. et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 11, 1311-1318, doi: 10.1038/nn.2213 (2008).
35. Iuliano, L. et al. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 36, 545-553, doi: 10.3233/JAD-122224 (2013).
36. Wang, G. et al. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment. J Proteome Res 13, 2649-2658, doi: 10.1021/pr5000895 (2014).
37. Dhillon, H. S., Dose, J. M., Scheff, S. W., Prasad, M. R. Time course of changes in lactate and free fatty acids after experimental brain injury and relationship to morphologic damage. Exp Neurol 146, 240-249, doi: 10.1006/exnr.1997.6524 (1997).
38. Sanchez-Mejia, R. O., Mucke, L. Phospholipase A2 and arachidonic acid in Alzheimer's disease. Biochim Biophys Acta 1801, 784-790, doi: 10.1016/j.bbalip.2010.05.013 (2010).
39. Yang, S. et al. Arachidonic acid: a bridge between traumatic brain injury and fracture healing. J Neurotrauma 29, 2696-2705, doi: 10.1089/neu.2012.2442 (2012).
40. Nekludov, M., Bellander, B. M., Blomback, M., Wallen, H. N. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma 24, 1699-1706, doi: 10.1089/neu.2007.0322 (2007).
41. Patil, S., Sheng, L., Masserang, A., Chan, C. Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons. Neurosci Lett 406, 55-59, doi: 10.1016/j.neulet.2006.07.015 (2006).
42. Fisher, D. R., Poulose, S. M., Bielinski, D. F., Shukitt-Hale, B. Serum metabolites from walnut-fed aged rats attenuate stress-induced neurotoxicity in BV-2 microglial cells. Nutr Neurosci, doi: 10.1179/1476830514Y.0000000150 (2014).
43. Teul, J. et al. Targeted and non-targeted metabolic time trajectory in plasma of patients after acute coronary syndrome. J Pharm Biomed Anal 56, 343-351, doi: 10.1016/j.jpba.2011.05.020 (2011).
44. Wang, H. et al. Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model. J Alzheimers Dis 39, 841-848, doi: 10.3233/JAD-131463 (2014).
45. Sivanandam, T. M., Thakur, M. K. Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci Biobehav Rev 36, 1376-1381, doi: 10.1016/j.neubiorev.2012.02.013 (2012).
46. Plassman, B. L., Grafman, J. Traumatic brain injury and late-life dementia. Handb Clin Neurol 128, 711-722, doi: 10.1016/B978-0-444-63521-1.00044-3 (2015).
47. Mortimer, J. A. et al. Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20 Suppl 2, S28-35 (1991).
48. Wang, H. K. et al. Population based study on patients with traumatic brain injury suggests increased risk of dementia. J Neurol Neurosurg Psychiatry 83, 1080-1085, doi: 10.1136/jnnp-2012-302633 (2012).
49. Plassman, B. L. et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55, 1158-1166 (2000).
50. Guo, Z. et al. Head injury and the risk of AD in the MIRAGE study. Neurology 54, 1316-1323 (2000).
51. Johnson, V. E., Stewart, W., Smith, D. H. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol 22, 142-149, doi: 10.1111/j.1750-3639.2011.00513.x (2012).
52. Magnoni, S., Brody, D. L. New perspectives on amyloid-beta dynamics after acute brain injury: moving between experimental approaches and studies in the human brain. Arch Neurol 67, 1068-1073, doi: 10.1001/archneurol.2010.214 (2010).
53. Ikonomovic, M. D. et al. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 190, 192-203, doi: 10.1016/j.expneurol.2004.06.011 (2004).
54. Uryu, K. et al. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol 208, 185-192, doi: 10.1016/j.expneurol.2007.06.018 (2007).
55. Marklund, N. et al. Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury. J Neurosurg 110, 1227-1237, doi: 10.3171/2008.9.JNS08584 (2009).
56. Norup, A., Kristensen, K. S., Siert, L., Poulsen, I., Mortensen, E. L. Neuropsychological support to relatives of patients with severe traumatic brain injury in the sub-acute phase. Neuropsychol Rehabil 21, 306-321, doi: 10.1080/09602011.2011.558766 (2011).
57. Gouvier, W. D., Blanton, P. D., LaPorte, K. K., Nepomuceno, C. Reliability and validity of the Disability Rating Scale and the Levels of Cognitive Functioning Scale in monitoring recovery from severe head injury. Arch Phys Med Rehabil 68, 94-97 (1987).